11
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Loxoribine Affects Fludarabine Activity on Freshly Isolated B-chronic Lymphocytic Leukemia Cells

, , , , &
Pages 343-348 | Received 10 Oct 1996, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Annalisa Pellacani, Patrizia Tosi, Pier Luigizinzani, Emanuela Ottaviani, Patrizia Albertini, Massimo Magagnoli & Sante Tura. (1999) Cytotoxic Combination of Loxoribine with Fludarabine and Mafosfamide on Freshly Isolated B-Chronic Lymphocytic Leukemia Cells. Leukemia & Lymphoma 33:1-2, pages 147-153.
Read now

Articles from other publishers (7)

Huju Chi, Chunman Li, Flora Sha Zhao, Li Zhang, Tzi Bun Ng, Guangyi Jin & Ou Sha. (2017) Anti-tumor Activity of Toll-Like Receptor 7 Agonists. Frontiers in Pharmacology 8.
Crossref
Sarang Tartey & Osamu Takeuchi. 2014. Cancer and Inflammation Mechanisms. Cancer and Inflammation Mechanisms 83 102 .
Anna Wolska, Ewa Lech-Marańda & Tadeusz Robak. (2009) Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. Cellular and Molecular Biology Letters 14:2.
Crossref
Anne F. McGettrick & Luke A. J. O'Neill. (2007) Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis. British Journal of Haematology 139:2, pages 185-193.
Crossref
D E Spaner & A Masellis. (2006) Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia. Leukemia 21:1, pages 53-60.
Crossref
D E Spaner, Y Shi, D White, J Mena, C Hammond, J Tomic, L He, M A Tomai, R L Miller, J Booth & L Radvanyi. (2005) Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells. Leukemia 20:2, pages 286-295.
Crossref
Chadi Nabhan, Ronald B Gartenhaus & Martin S Tallman. (2004) Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era. Leukemia Research 28:5, pages 429-442.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.